Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.

Market Analysis and Insights: Global Interventional Oncology Market
The global Interventional Oncology market size is projected to reach US$ 2270.5 million by 2027, from US$ 1689.3 million in 2020, at a CAGR of 3.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Interventional Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Interventional Oncology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Interventional Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Interventional Oncology market.

Global Interventional Oncology Scope and Market Size
Interventional Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interventional Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ablation Devices
Embolization Devices
Support Devices

Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical